Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03140202
Other study ID # A16-D51-VOL.30
Secondary ID
Status Recruiting
Phase N/A
First received April 24, 2017
Last updated July 18, 2017
Start date April 18, 2017
Est. completion date October 1, 2017

Study information

Verified date April 2017
Source University Hospital, Caen
Contact Clement BULEON, MD
Phone +(33)231064736
Email buleon-c@chu-caen.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Context: Chest compressions quality is known to be essential in cardiopulmonary resuscitation. Despite a known harmful effect of chest compressions interruptions, current guidelines still recommend provider switch every 2 minutes. Feedback impact on chest compressions quality preservation during cardiopulmonary resuscitation remains to be assessed.

Study design: simulated prospective monocentric randomized crossover trial.

Participants and methods: Sixty five professionals rescuers of the pre-hospital care unit of University Hospital of Caen (doctors, nurses and ambulance drivers) are enrolled to performed continuous chest compression on manikin (ResusciAnne®, Laerdal), twice, with and without a feedback device (CPRmeter®). Correct compression score (the main criterion) is defined by reached target of rate, depth and leaning at the same time (recorded continuously).

Hypothesis: Feedback device preserve chest compression quality above the 2 minutes recommended switch over during cardiopulmonary resuscitation.


Recruitment information / eligibility

Status Recruiting
Enrollment 65
Est. completion date October 1, 2017
Est. primary completion date September 15, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Operational staff of University hospital of Caen pre-hospital unit

- Ability in CardioPulmonary Resuscitation

Exclusion Criteria:

- medical contraindication

- refusal

Study Design


Related Conditions & MeSH terms


Intervention

Device:
CPRmeter (feedback device) with feedback
Participants have a real time feedback and record.
CPRmeter (feedback device) without feedback
Participants have a real time record without feedback.

Locations

Country Name City State
France University Hospital of Caen Caen Normandy

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Caen

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Other Hemodynamic effect n1 of Cardiopulmonary Resuscitation Impact of Cardiopulmonary Resuscitation effort on participant blood pressure (mmHg) Day 0
Other Hemodynamic effect n2 of Cardiopulmonary Resuscitation Impact of Cardiopulmonary Resuscitation effort on participant heart frequency (/min) Day 0
Primary Correct compression score Correct compression score is defined by reached target of rate (between 100/min and 120/min), depth (between 50 mm and 60 mm) and leaning (less than 2500g) at the same time Day 0
Secondary Decrease time of 30% of correct compression score Time at witch correct compression score decrease of 30% of the reference correct compression score (first 20 secondes) Day 0
Secondary Chest compression depth Chest compression depth reached (in mm) Day 0
Secondary Chest compression rate Chest compression rate per min Day 0
Secondary Percentage of chest compression without leaning Percentage of chest compression without leaning defined with a residual weight egal or above 2500 g Day 0
Secondary Percentage of chest compression with correct depth Percentage of chest compression with depth between 50 mm and 60 mm Day 0
Secondary Percentage of correct chest compression rate Percentage chest compression rate between 100/min and 120/min Day 0
Secondary Participants' fatigue (Borg's scale) Participant auto-evaluation of fatigue with a predefined scale from 6 to 20 (no unit). Day 0
See also
  Status Clinical Trial Phase
Recruiting NCT06048068 - Removing Surrogates' Uncertainty to Reduce Fear and Anxiety After Cardiac Events N/A
Recruiting NCT05558228 - Accuracy of Doppler Ultrasound Versus Manual Palpation of Pulse in Cardiac Arrest
Completed NCT03685383 - Cytokine Adsorption in Post-cardiac Arrest Syndrome in Patients Requiring Extracorporeal Cardiopulmonary Resuscitation N/A
Completed NCT04584645 - A Digital Flu Intervention for People With Cardiovascular Conditions N/A
Completed NCT04619498 - Effectiveness of an Interactive Cognitive Support Tablet App to Improve the Management of Pediatric Cardiac Arrest N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Withdrawn NCT02352350 - Lactate in Cardiac Arrest N/A
Completed NCT03024021 - Cerebral Oxymetry and Neurological Outcome in Therapeutic Hypothermia
Completed NCT02247947 - Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome
Completed NCT02275234 - Care After Resuscitation
Completed NCT01972087 - Simulation Training to Improve 911 Dispatcher Identification of Cardiac Arrest N/A
Completed NCT01944605 - Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest N/A
Completed NCT01936597 - Prospective Study of 3 Phone Assistance Strategies to Achieve a Continuous Cardiac Massage N/A
Active, not recruiting NCT01239420 - Norwegian Cardio-Respiratory Arrest Study
Completed NCT01191736 - Ultra-Brief Versus Brief Hands Only CPR Video Training With and Without Psychomotor Skill Practice N/A
Completed NCT00880087 - Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-IH [In Hospital] Trial N/A
Completed NCT00878644 - Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-OH [Out of Hospital] Trial Phase 3
Completed NCT00729794 - Vasopressin, Epinephrine, and Steroids for Cardiac Arrest Phase 3
Recruiting NCT00441753 - Cerebral Bloodflow and Carbondioxide Reactivity During Mild Therapeutic Hypothermia in Patients After Cardiac Arrest N/A
Completed NCT00347477 - Fluid Shifts in Patients Treated With Therapeutic Hypothermia After Cardiac Arrest Phase 3